Synonyms: ABBV-CLS-7262 | compound 131 [US20220251123A1]
Compound class:
Synthetic organic
Comment: The structure for fosigotifator was obtained from proposed INN list 129 (August 2023) where it is described as a eukaryotic translation initiation factor 2B (eIF2B) activator. Fosigotifator is one of the prodrug compounds claimed in patent US20220251123A1 [2]. It is likely that this is the Abbvie/Calico oral, CNS-penetrant clinical lead ABBV-CLS-7262, that is designed to activate eIF2B and thereby modulate the integrated stress response (ISR) [4] as a mechanism to treat a range of conditions, including neurodegenerative and metabolic diseases [1,3,5].
|
|
Download 2D Structure ![]() |
|
Canonical SMILES | Download |
Isomeric SMILES | Download |
InChI standard identifier | Download |
InChI standard key | Download |
Molecular structure representations generated using Open Babel